Beta-blockade: metabolic effects in experimental myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002395:Catecholamines / Q000009:adverse effects*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism*; D011433:Propranolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011433:Propranolol